Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

Drug interactions between tacrolimus and clotrimazole troche: a data mining approach followed by a pharmacokinetic study.

Uno T, Wada K, Hosomi K, Matsuda S, Ikura MM, Takenaka H, Terakawa N, Oita A, Yokoyama S, Kawase A, Takada M.

Eur J Clin Pharmacol. 2019 Oct 26. doi: 10.1007/s00228-019-02770-6. [Epub ahead of print]

PMID:
31654150
2.

Clotrimazole troches can alter everolimus pharmacokinetics in post-transplant patients: A case report.

Uno T, Wada K, Matsuda S, Ikura M, Takenaka H, Terakawa N, Oita A, Yokoyama S, Kawase A, Hosomi K, Takada M.

Br J Clin Pharmacol. 2019 Sep;85(9):2176-2178. doi: 10.1111/bcp.14017. Epub 2019 Jun 26. No abstract available.

PMID:
31243774
3.

Effects of clotrimazole on tacrolimus pharmacokinetics in patients with heart transplants with different CYP3A5 genotypes.

Uno T, Wada K, Matsuda S, Terada Y, Terakawa N, Oita A, Yokoyama S, Kawase A, Hosomi K, Takada M.

Eur J Clin Pharmacol. 2019 Jan;75(1):67-75. doi: 10.1007/s00228-018-2558-6. Epub 2018 Sep 25.

PMID:
30251062
4.

Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD).

Nakagita K, Wada K, Mukai Y, Uno T, Nishino R, Matsuda S, Takenaka H, Terakawa N, Oita A, Takada M.

Eur J Clin Pharmacol. 2018 Jul;74(7):885-894. doi: 10.1007/s00228-018-2483-8. Epub 2018 May 21.

PMID:
29781049
5.

Effect of fluconazole on the pharmacokinetics of everolimus and tacrolimus in a heart transplant recipient: Case report.

Nakagita K, Wada K, Terada Y, Matsuda S, Terakawa N, Oita A, Takada M.

Int J Clin Pharmacol Ther. 2018 Jun;56(6):270-276. doi: 10.5414/CP203209.

PMID:
29648533
6.

Clinical characteristics of patients in Japan with ovarian cancer presumably arising from ovarian endometrioma.

Taniguchi F, Harada T, Kobayashi H, Hayashi K, Momoeda M, Terakawa N.

Gynecol Obstet Invest. 2014;77(2):104-10. doi: 10.1159/000357819. Epub 2014 Feb 5.

PMID:
24503885
7.

Epigenetic aberration of gene expression in endometriosis.

Izawa M, Taniguchi F, Terakawa N, Harada T.

Front Biosci (Elite Ed). 2013 Jun 1;5:900-10. Review.

PMID:
23747905
8.

Fibroblast growth factor receptor 2 expression may be involved in transformation of ovarian endometrioma to clear cell carcinoma of the ovary.

Taniguchi F, Itamochi H, Harada T, Terakawa N.

Int J Gynecol Cancer. 2013 Jun;23(5):791-6. doi: 10.1097/IGC.0b013e31828f38c4.

PMID:
23640291
9.

Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.

Itamochi H, Kato M, Nishimura M, Oumi N, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Nonaka M, Kudoh A, Terakawa N, Kigawa J, Harada T.

Hum Cell. 2013 Sep;26(3):121-7. doi: 10.1007/s13577-013-0062-y. Epub 2013 Feb 21.

PMID:
23430509
10.

Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2.

Itamochi H, Kato M, Nishimura M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Nonaka M, Kudoh A, Terakawa N, Kigawa J, Harada T.

Hum Cell. 2012 Dec;25(4):111-5. doi: 10.1007/s13577-012-0048-1. Epub 2012 Dec 30.

PMID:
23274876
11.

Gonadotropin-releasing hormone analogues reduce the proliferation of endometrial stromal cells but not endometriotic cells.

Taniguchi F, Higaki H, Azuma Y, Deura I, Iwabe T, Harada T, Terakawa N.

Gynecol Obstet Invest. 2013;75(1):9-15. doi: 10.1159/000343748. Epub 2012 Nov 8.

PMID:
23147672
12.

Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.

Nonaka M, Itamochi H, Kawaguchi W, Kudoh A, Sato S, Uegaki K, Naniwa J, Sato S, Shimada M, Oishi T, Terakawa N, Kigawa J, Harada T.

Int J Gynecol Cancer. 2012 Jul;22(6):922-9. doi: 10.1097/IGC.0b013e31824f0b13.

PMID:
22672985
13.

The role of NF-kappaB in endometriosis.

Kaponis A, Iwabe T, Taniguchi F, Ito M, Deura I, Decavalas G, Terakawa N, Harada T.

Front Biosci (Schol Ed). 2012 Jun 1;4:1213-34. Review.

PMID:
22652867
14.

Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27.

Itamochi H, Yoshida T, Walker CL, Bartholomeusz C, Aoki D, Ishihara H, Suzuki N, Kigawa J, Terakawa N, Ueno NT.

Gynecol Oncol. 2011 Sep;122(3):641-7. doi: 10.1016/j.ygyno.2011.05.003. Epub 2011 Jun 8.

PMID:
21652059
15.

Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun.

Itamochi H, Oishi T, Shimada M, Sato S, Uegaki K, Naniwa J, Sato S, Nonaka M, Terakawa N, Kigawa J, Harada T.

Clin Cancer Res. 2011 Jul 15;17(14):4742-50. doi: 10.1158/1078-0432.CCR-11-0190. Epub 2011 May 24.

16.

Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial.

Harada T, Momoeda M, Terakawa N, Taketani Y, Hoshiai H.

Fertil Steril. 2011 May;95(6):1928-31. doi: 10.1016/j.fertnstert.2011.02.045. Epub 2011 Mar 21.

PMID:
21420678
17.

Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer.

Takekida S, Fujiwara K, Nagao S, Yamaguchi S, Yoshida N, Kitada F, Kigawa J, Terakawa N, Nishimura R.

Int J Gynecol Cancer. 2010 Dec;20(9):1563-8.

PMID:
21370599
18.

Apoptosis and endometriosis.

Taniguchi F, Kaponis A, Izawa M, Kiyama T, Deura I, Ito M, Iwabe T, Adonakis G, Terakawa N, Harada T.

Front Biosci (Elite Ed). 2011 Jan 1;3:648-62. Review.

PMID:
21196342
19.

Circulating myeloid dendritic cells as prognostic factors in patients with pancreatic cancer who have undergone surgical resection.

Yamamoto T, Yanagimoto H, Satoi S, Toyokawa H, Yamao J, Kim S, Terakawa N, Takahashi K, Kwon AH.

J Surg Res. 2012 Apr;173(2):299-308. doi: 10.1016/j.jss.2010.09.027. Epub 2010 Oct 16.

PMID:
21195425
20.

Apigenin inhibits tumor necrosis factor α-induced cell proliferation and prostaglandin E2 synthesis by inactivating NFκB in endometriotic stromal cells.

Suou K, Taniguchi F, Tagashira Y, Kiyama T, Terakawa N, Harada T.

Fertil Steril. 2011 Mar 15;95(4):1518-21. doi: 10.1016/j.fertnstert.2010.09.046. Epub 2010 Nov 10.

PMID:
21067731
21.

Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues.

Izawa M, Taniguchi F, Uegaki T, Takai E, Iwabe T, Terakawa N, Harada T.

Fertil Steril. 2011 Jan;95(1):33-9. doi: 10.1016/j.fertnstert.2010.06.024. Epub 2010 Jul 23.

PMID:
20655525
22.

Long-term use of dienogest for the treatment of endometriosis.

Momoeda M, Harada T, Terakawa N, Aso T, Fukunaga M, Hagino H, Taketani Y.

J Obstet Gynaecol Res. 2009 Dec;35(6):1069-76. doi: 10.1111/j.1447-0756.2009.01076.x.

PMID:
20025633
23.

The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis.

Watanabe A, Taniguchi F, Izawa M, Suou K, Uegaki T, Takai E, Terakawa N, Harada T.

Hum Reprod. 2009 Dec;24(12):3172-9. doi: 10.1093/humrep/dep305. Epub 2009 Sep 3.

PMID:
19729377
24.

Lipopolysaccharide promoted proliferation and invasion of endometriotic stromal cells via induction of cyclooxygenase-2 expression.

Takenaka Y, Taniguchi F, Miyakoda H, Takai E, Terakawa N, Harada T.

Fertil Steril. 2010 Jan;93(1):325-7. doi: 10.1016/j.fertnstert.2009.06.042. Epub 2009 Jul 31.

PMID:
19647233
25.

Body mass index is a useful predictor of prognosis after left ventricular assist system implantation.

Mano A, Fujita K, Uenomachi K, Kazama K, Katabuchi M, Wada K, Terakawa N, Arai K, Hori Y, Hashimoto S, Nakatani T, Kitamura S.

J Heart Lung Transplant. 2009 May;28(5):428-33. doi: 10.1016/j.healun.2008.12.020.

PMID:
19416769
26.

TAK1 activation for cytokine synthesis and proliferation of endometriotic cells.

Taniguchi F, Harada T, Miyakoda H, Iwabe T, Deura I, Tagashira Y, Miyamoto A, Watanabe A, Suou K, Uegaki T, Terakawa N.

Mol Cell Endocrinol. 2009 Aug 13;307(1-2):196-204. doi: 10.1016/j.mce.2009.04.012. Epub 2009 May 3.

PMID:
19410630
27.

TNFalpha gene silencing reduced lipopolysaccharide-promoted proliferation of endometriotic stromal cells.

Miyamoto A, Taniguchi F, Tagashira Y, Watanabe A, Harada T, Terakawa N.

Am J Reprod Immunol. 2009 Apr;61(4):277-85. doi: 10.1111/j.1600-0897.2009.00691.x.

PMID:
19260858
28.

Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.

Sato S, Itamochi H, Kigawa J, Oishi T, Shimada M, Sato S, Naniwa J, Uegaki K, Nonaka M, Terakawa N.

Cancer Sci. 2009 Mar;100(3):546-51. doi: 10.1111/j.1349-7006.2008.01065.x. Epub 2008 Dec 19.

29.

Involvement of thioredoxin-binding protein 2 in the antitumor activity of CD437.

Matsuoka S, Tsuchiya H, Sakabe T, Watanabe Y, Hoshikawa Y, Kurimasa A, Itamochi H, Harada T, Terakawa N, Masutani H, Yodoi J, Shiota G.

Cancer Sci. 2008 Dec;99(12):2485-90. doi: 10.1111/j.1349-7006.2008.00979.x. Epub 2008 Nov 17.

30.

Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.

Kawaguchi W, Itamochi H, Kigawa J, Kanamori Y, Oishi T, Shimada M, Sato S, Sato S, Terakawa N.

Int J Clin Oncol. 2008 Oct;13(5):461-3. doi: 10.1007/s10147-008-0767-1. Epub 2008 Oct 23.

PMID:
18946759
31.

Novel therapeutic targets for GnRH analogues in the treatment of endometriosis and current approaches to optimizing GnRH analogue therapy. Introduction.

Hoshiai H, Terakawa N.

Gynecol Obstet Invest. 2008;66 Suppl 1:1-2. doi: 10.1159/000148024. Epub 2008 Oct 21. No abstract available.

32.

Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial.

Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y.

Nutr Cancer. 2008;60(5):643-51. doi: 10.1080/01635580801993280.

PMID:
18791928
33.

Interleukin-10 attenuates TNF-alpha-induced interleukin-6 production in endometriotic stromal cells.

Tagashira Y, Taniguchi F, Harada T, Ikeda A, Watanabe A, Terakawa N.

Fertil Steril. 2009 May;91(5 Suppl):2185-92. doi: 10.1016/j.fertnstert.2008.04.052. Epub 2008 Aug 5.

PMID:
18684450
34.

Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial.

Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H, Terakawa N.

Fertil Steril. 2009 Mar;91(3):675-81. doi: 10.1016/j.fertnstert.2007.12.080. Epub 2008 Jul 23.

PMID:
18653184
35.

Serum interleukin-8 levels are elevated in patients with ovarian endometrioma.

Ohata Y, Harada T, Miyakoda H, Taniguchi F, Iwabe T, Terakawa N.

Fertil Steril. 2008 Oct;90(4):994-9. doi: 10.1016/j.fertnstert.2007.07.1355. Epub 2008 Jul 16.

PMID:
18635170
36.

Cytochrome P450 aromatase gene (CYP19) expression in gastric cancer.

Izawa M, Inoue M, Osaki M, Ito H, Harada T, Terakawa N, Ikeguchi M.

Gastric Cancer. 2008;11(2):103-10. doi: 10.1007/s10120-008-0463-x. Epub 2008 Jul 2.

PMID:
18595017
37.

Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.

Shimogai R, Kigawa J, Itamochi H, Iba T, Kanamori Y, Oishi T, Shimada M, Sato S, Kawaguchi W, Sato S, Terakawa N.

Int J Gynecol Cancer. 2008 May-Jun;18(3):499-505. doi: 10.1111/j.1525-1438.2007.01055.x.

PMID:
18476949
38.

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.

Itamochi H, Kigawa J, Terakawa N.

Cancer Sci. 2008 Apr;99(4):653-8. doi: 10.1111/j.1349-7006.2008.00747.x. Review.

39.

Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.

Takai S, Satoi S, Yanagimoto H, Toyokawa H, Takahashi K, Terakawa N, Araki H, Matsui Y, Sohgawa M, Kamiyama Y.

Pancreas. 2008 Jan;36(1):e26-32. doi: 10.1097/mpa.0b013e31814b229a.

PMID:
18192876
40.

Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.

Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N.

Fertil Steril. 2008 Nov;90(5):1583-8. doi: 10.1016/j.fertnstert.2007.08.051. Epub 2007 Dec 27.

PMID:
18164001
41.

Circulating dendritic cells and development of septic complications after pancreatectomy for pancreatic cancer.

Takahashi K, Satoi S, Yanagimoto H, Terakawa N, Toyokawa H, Yamamoto T, Matsui Y, Takai S, Kwon AH, Kamiyama Y.

Arch Surg. 2007 Dec;142(12):1151-7; discussion 1157.

PMID:
18086981
42.

CD437 induces apoptosis in ovarian adenocarcinoma cells via ER stress signaling.

Watanabe Y, Tsuchiya H, Sakabe T, Matsuoka S, Akechi Y, Fujimoto Y, Yamane K, Ikeda R, Nishio R, Terabayashi K, Ishii K, Gonda K, Matsumi Y, Ashla AA, Okamoto H, Takubo K, Tomita A, Hoshikawa Y, Kurimasa A, Itamochi H, Harada T, Terakawa N, Shiota G.

Biochem Biophys Res Commun. 2008 Feb 15;366(3):840-7. Epub 2007 Dec 17.

PMID:
18082618
43.

Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results.

Fujii S, Matsusue E, Kigawa J, Sato S, Kanasaki Y, Nakanishi J, Sugihara S, Kaminou T, Terakawa N, Ogawa T.

Eur Radiol. 2008 Feb;18(2):384-9. Epub 2007 Oct 5.

PMID:
17917730
44.

Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma.

Kawaguchi W, Itamochi H, Kigawa J, Kanamori Y, Oishi T, Shimada M, Sato S, Shimogai R, Sato S, Terakawa N.

Cancer Sci. 2007 Dec;98(12):2002-8. Epub 2007 Sep 26.

45.

Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging.

Fujii S, Matsusue E, Kanasaki Y, Kanamori Y, Nakanishi J, Sugihara S, Kigawa J, Terakawa N, Ogawa T.

Eur Radiol. 2008 Jan;18(1):18-23. Epub 2007 Aug 14.

PMID:
17701040
46.

An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells.

Izawa M, Harada T, Taniguchi F, Ohama Y, Takenaka Y, Terakawa N.

Fertil Steril. 2008 May;89(5 Suppl):1390-6. Epub 2007 Jul 26.

PMID:
17662285
47.

Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection.

Matsui Y, Terakawa N, Satoi S, Kaibori M, Kitade H, Takai S, Kwon AH, Kamiyama Y.

Arch Surg. 2007 Jul;142(7):596-602; discussion 603.

PMID:
17638795
48.

Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua.

Shoji T, Yoshida S, Mitsunari M, Miyake N, Tsukihara S, Iwabe T, Harada T, Terakawa N.

J Reprod Immunol. 2007 Oct;75(2):82-90. Epub 2007 Jul 6.

PMID:
17617469
49.

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.

Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, Hatae M, Kodama S, Saito T, Terakawa N, Yaegashi N, Hiura M, Sakamoto A, Tsuda H, Fukunaga M, Kamura T.

J Clin Oncol. 2007 Jul 1;25(19):2798-803.

PMID:
17602085
50.

Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.

Ohama Y, Harada T, Iwabe T, Taniguchi F, Takenaka Y, Terakawa N.

Fertil Steril. 2008 Feb;89(2):311-7. Epub 2007 Jun 6.

PMID:
17555752

Supplemental Content

Loading ...
Support Center